MABF41 | Anti-Interleukin-6 (IL-6) Antibody, clone 1G3

MABF41
100 µg  
価格を検索中…
価格が見つかりません
Minimum Quantity needs to be mulitiple of
弊社照会 詳細を表示 
値引
()
 
弊社照会
現在国内在庫なし現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください

      Special Offers[海外情報]

       

      お問合せください

      クリックして印刷用に表示

      概要

      Replacement Information

      Special Offers[海外情報]

      主要スペック表

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H WB M Purified Monoclonal Antibody
      Description
      Catalogue NumberMABF41
      Replaces04-1095
      DescriptionAnti-Interleukin-6 (IL-6) Antibody, clone 1G3
      Alternate Names
      • interleukin 6 (interferon, beta 2)
      • IFN-beta-2
      • B-cell stimulatory factor 2
      • interleukin-6
      • Interferon beta-2
      • B cell stimulatory factor-2
      • Hybridoma growth factor
      • B-cell differentiation factor
      • CTL differentiation factor
      • interleukin BSF-2
      Background InformationInterleukin-6 (IL-6) is a pro-inflammatory cytokine that seems to be involved in the late stages of CTL generation. Other biological functions also include amplification and the inflammatory response. Combination therapies including IL-6 have been shown to have positive effects on specific malignant tumor types. The accumulation of IL-6 in the CNS is usually detrimental and can contribute to pathology of CNS diseases. IL-6 signaling is negatively regulated by TGF-beta, which down regulates STAT1, STAT3 and ICAM-1 expression. IL-6 expression has been linked to inflammatory bowel disease (IBD) and is also the primary clinical target for IBD. Clinical use of an antibody for the IL-6 receptor (IL-6R) has been promising in treating rheumatoid arthritis, systemic juvenile idiopathic arthritis and Castleman’s disease.
      References
      Product Information
      FormatPurified
      Control
      • Human IL-6 recombinant protein
      PresentationPurified mouse monoclonal IgG2bκ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Applications
      ApplicationAnti-Interleukin-6 (IL-6) Antibody, clone 1G3 is an antibody against Interleukin-6 (IL-6) for use in WB.
      Key Applications
      • Western Blotting
      Biological Information
      ImmunogenHuman IL-6 fused to the soluble domain of the IL-6R.
      CloneAB42_51.38C8.1G3
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostMouse
      IsotypeIgG2bκ
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryThis gene encodes a cytokine that functions in inflammation and the maturation of B cells. The protein is primarily produced at sites of acute and chronic inflammation, where it is secreted into the serum and induces a transcriptional inflammatory response through interleukin 6 receptor, alpha. The functioning of this gene is implicated in a wide variety of inflammation-associated disease states, including suspectibility to diabetes mellitus and systemic juvenile rheumatoid arthritis. [provided by RefSeq].
      Gene Symbol
      • IL6
      • IL-6
      • CDF
      • HSF
      • HGF
      • BSF2
      • IFNB2
      • BSF-2
      Purification MethodProtein G Purified
      UniProt Number
      UniProt SummaryFUNCTION: Cytokine with a wide variety of biological functions. It is a potent inducer of the acute phase response. Plays an essential role in the final differentiation of B-cells into Ig-secreting cells Involved in lymphocyte and monocyte differentiation. It induces myeloma and plasmacytoma growth and induces nerve cells differentiation Acts on B-cells, T-cells, hepatocytes, hematopoeitic progenitor cells and cells of the CNS. Also acts as a myokine. It is discharged into the bloodstream after muscle contraction and acts to increase the breakdown of fats and to improve insulin resistance.

      SUBCELLULAR LOCATION: Secreted.

      PTM: N- and O-glycosylated.

      POLYMORPHISM: Genetic variations in IL6 may be correlated with bone mineral density (BMD). Low BMD is a risk factor for osteoporotic fracture. Osteoporosis is characterized by reduced bone mineral density, disrutption of bone microarchitecture, and the alteration of the amount and variety of non-collagenous proteins in bone. Osteoporotic bones are more at risk of fracture.

      INVOLVEMENT IN DISEASE: Genetic variations in IL6 are associated with susceptibility to rheumatoid arthritis systemic juvenile (RASJ) [MIM:604302]. An inflammatory articular disorder with systemic-onset beginning before the age of 16. It represents a subgroup of juvenile arthritis associated with severe extraarticular features and occasionally fatal complications. During active phases of the disorder, patients display a typical daily spiking fever, an evanescent macular rash, lymphadenopathy, hepatosplenomegaly, serositis, myalgia and arthritis.

      Note=A IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in HIV-infected men.

      SEQUENCE SIMILARITIES: Belongs to the IL-6 superfamily.
      Molecular Weight~21 kDa observed
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blot in lysate from cells expressing human IL-6 recombinant protein.

      Western Blot Analysis: 0.5 µg/mL of this antibody detected 10 µg of human IL-6 recombinant protein.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      試験成績書(CoA)

      タイトルロット番号
      Anti-Interleukin-6 (IL-6), clone 1G3 - 2383996 2383996
      Anti-Interleukin-6 (IL-6), clone 1G3 - 1963085 1963085
      Anti-Interleukin-6 (IL-6), clone 1G3 - 2224490 2224490
      Anti-Interleukin-6 (IL-6), clone 1G3 - NRG1843224 NRG1843224
      Anti-Interleukin-6 (IL-6), clone 1G3 -2606916 2606916
      Anti-Interleukin-6 (IL-6), clone 1G3 -2637129 2637129
      Anti-Interleukin-6 (IL-6), clone 1G3 -2665819 2665819
      Anti-Interleukin-6 (IL-6), clone 1G3 -2887640 2887640
      Anti-Interleukin-6 (IL-6), clone 1G3 Monoclonal Antibody 3015354
      Anti-Interleukin-6 (IL-6), clone 1G3 Monoclonal Antibody 2944485

      関連製品&アプリケーション

      Related Products

      カタログ番号 説明  
      AB1423 Anti-Interleukin-6 Antibody 価格&在庫状況を表示
      AB1431 Anti-Interferon-β Antibody 価格&在庫状況を表示
      AB1839 Anti-Interleukin-6 Antibody 価格&在庫状況を表示
      CBL2117 Anti-Interleukin-6 Antibody, clone B-E8 価格&在庫状況を表示
      MAB1004 Anti-Interleukin-6 Antibody, clone 4B6 価格&在庫状況を表示
      MAB416 Anti-Interferon-β Antibody, clone A1 価格&在庫状況を表示
      MABF342 Anti-IL-6 (human) Antibody, FITC, clone MQ2-13A5 価格&在庫状況を表示

      カテゴリー

      Life Science Research > Antibodies and Assays > Primary Antibodies